Rhodin, K. E., Jung, S.-H., Elleson, K., DePalo, D., Straker, R., McKinley, S., … Beasley, G. M. (2023). ASO Visual Abstract: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does It Matter? Ann Surg Oncol, 30(11), 6355–6356. https://doi.org/10.1245/s10434-023-14089-9

Rhodin, Kristen E., Sin-Ho Jung, Kelly Elleson, Danielle DePalo, Richard Straker, Sophia McKinley, Kate Beekman, et al. “ASO Visual Abstract: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does It Matter?” Ann Surg Oncol 30, no. 11 (October 2023): 6355–56. https://doi.org/10.1245/s10434-023-14089-9.

Rhodin KE, Jung S-H, Elleson K, DePalo D, Straker R, McKinley S, et al. ASO Visual Abstract: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does It Matter? Ann Surg Oncol. 2023 Oct;30(11):6355–6.

Rhodin, Kristen E., et al. “ASO Visual Abstract: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does It Matter?” Ann Surg Oncol, vol. 30, no. 11, Oct. 2023, pp. 6355–56. Pubmed, doi:10.1245/s10434-023-14089-9.

Rhodin KE, Jung S-H, Elleson K, DePalo D, Straker R, McKinley S, Beekman K, Parker L, Chen S, Iyer MK, Salama AKS, Bartlett E, Karakousis G, Zager JS, Tyler DS, Beasley GM. ASO Visual Abstract: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does It Matter? Ann Surg Oncol. 2023 Oct;30(11):6355–6356.